Carole Huntsman is Chief Commercial Officer of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 11,990 shares of MDGL, which is worth approximately $3.93 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 3,386 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K
11.17% 3M change
4.51% 12M change
Total Value Held $3.93 Million

Carole Huntsman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2025
BUY
Grant, award, or other acquisition
-
3,386 Added 22.02%
11,990 Common Stock
Mar 03 2025
SELL
Open market or private sale
$593,959 $323.86 p/Share
1,834 Reduced 17.57%
8,604 Common Stock
Jan 24 2025
SELL
Open market or private sale
$116,328 $335.24 p/Share
347 Reduced 3.22%
10,438 Common Stock
Nov 21 2024
SELL
Open market or private sale
$218,040 $316.92 p/Share
688 Reduced 6.0%
10,785 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
3,639 Added 24.08%
11,473 Common Stock
Nov 20 2023
BUY
Grant, award, or other acquisition
-
7,834 Added 50.0%
7,834 Common Stock
CH

Carole Huntsman

Chief Commercial Officer
West Conshohocken, PA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Track Activities on MDGL